Back

Direct versus late maxLCBI4mm changes after paclitaxel-coated balloon treatment of lipid-rich plaques

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Prognosis post-acute coronary syndromes Vulnerable Plaque ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Tamara Dijkstra

Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Temporal trends in octo- and nonagenarians with ST-elevation-myocardial infarctions and impact of interventional results on prognosis
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Impact of female gender on prevalence rates, interventional strategies and prognosis in patients admitted with ST-elevation-myocardial infarction complicated by cardiogenic shock
Doctor A. Fach (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Implication of myocardial perfusion abnormalities on clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusions
Mr J. Henningsen (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Pre-myocardial infarction symptom and short- and long-term cardiovascular mortality among acute myocardial infarction patients
Doctor S. Inaba (Shizuoka, JP)
Abstract Slides Video
Presentation thumbnail
Fatal and non-fatal myocardial infarction in patients with possible angina referred for rapid outpatient assessment
Doctor M. Mcdermott (Edinburgh, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis post-acute coronary syndromes

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Treatment of coronary artery disease with sirolimus- versus paclitaxel-coated balloons
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources